161 related articles for article (PubMed ID: 28818531)
1. The position of fluorine in CP-118,954 affects AChE inhibition potency and PET imaging quantification for AChE expression in the rat brain.
Lee BC; Moon BS; Park HS; Jung JH; Park HS; Park DD; de Candia M; Denora N; Altomare CD; Kim SE
Eur J Pharm Sci; 2017 Nov; 109():209-216. PubMed ID: 28818531
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 5,7-dihydro-3-[2-[1-(4-[18F]-fluorobenzyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one for in vivo mapping of acetylcholinesterase.
Lee SY; Choe YS; Kim YR; Paik JY; Choi BW; Kim SE; Lee KH; Choi Y; Kim BT
Nucl Med Commun; 2004 Jun; 25(6):591-6. PubMed ID: 15167519
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of radioiodine-labelled CP-118,954 for the in-vivo imaging of acetylcholinesterase.
Lee I; Choe YS; Ryu EK; Choi BW; Choi JY; Choi Y; Lee KH; Kim BT
Nucl Med Commun; 2007 Jul; 28(7):561-6. PubMed ID: 17538398
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.
Bencherif B; Endres CJ; Musachio JL; Villalobos A; Hilton J; Scheffel U; Dannals RF; Williams S; Frost JJ
Synapse; 2002 Jul; 45(1):1-9. PubMed ID: 12112408
[TBL] [Abstract][Full Text] [Related]
5. Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies.
Kim DH; Choe YS; Choi JY; Lee KH; Kim BT
Nucl Med Biol; 2011 May; 38(4):541-7. PubMed ID: 21531291
[TBL] [Abstract][Full Text] [Related]
6. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase.
Ryu EK; Choe YS; Park EY; Paik JY; Kim YR; Lee KH; Choi Y; Kim SE; Kim BT
Nucl Med Biol; 2005 Feb; 32(2):185-91. PubMed ID: 15721764
[TBL] [Abstract][Full Text] [Related]
8. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and in vivo evaluation of fluorinated huprine derivates as PET radiotracers of acetylcholinesterase.
Da Costa Branquinho E; Becker G; Bouteiller C; Jean L; Renard PY; Zimmer L
Nucl Med Biol; 2013 May; 40(4):554-60. PubMed ID: 23522975
[TBL] [Abstract][Full Text] [Related]
10. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
11. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase.
Musachio JL; Flesher JE; Scheffel UA; Rauseo P; Hilton J; Mathews WB; Ravert HT; Dannals RF; Frost JJ
Nucl Med Biol; 2002 Jul; 29(5):547-52. PubMed ID: 12088724
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
15. 5,7-dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H- pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: a potent and centrally-selective inhibitor of acetylcholinesterase with an improved margin of safety.
Villalobos A; Butler TW; Chapin DS; Chen YL; DeMattos SB; Ives JL; Jones SB; Liston DR; Nagel AA; Nason DM
J Med Chem; 1995 Jul; 38(15):2802-8. PubMed ID: 7636841
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase.
Choe YS; Oh S; Shim I; Naruto S; Chi DY; Kim SE; Lee K; Choi Y; Kim B
Nucl Med Biol; 2000 Apr; 27(3):263-7. PubMed ID: 10832083
[TBL] [Abstract][Full Text] [Related]
17. Aminopyridazines as acetylcholinesterase inhibitors.
Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
[TBL] [Abstract][Full Text] [Related]
20. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
